Blog
Insights from the Invert team.
Perspectives on bioprocess data, AI in biomanufacturing, and building the intelligence layer for biopharma teams.
The Bioprocess Scale-Up Playbook: From Fragmented Data to Confident Decisions
Learn how leading pharma, biologics, and vaccine teams close the scale-up gap with unified data, real-time visibility, and a built-in bioprocess intelligence layer. See how Invert transforms fragmented bioprocess data into faster, more confident decisions across development and manufacturing.
Read article
AI in Bioprocess Quality Control: Moving from Compliance to Confidence
Learn how AI powered bioprocess quality control software helps pharma and cell therapy manufacturers improve consistency, strengthen GxP compliance, and shift from reactive oversight to confident, real time decision making.
Read article
Best Practices for Bioprocess Data Integration
Learn the key best practices for integrating bioprocess data across development, scale up, CDMOs, and manufacturing. Discover how harmonized, contextualized, AI ready data accelerates insight and reduces risk.
Read article
How to Scale Up Bioprocess Manufacturing Without the Data Headaches
Learn how bioprocess teams are scaling manufacturing faster with AI-powered intelligence platforms that unify data, simplify tech transfer, and reduce risk in cell therapy and pharmaceutical production.
Read article
Top AI Tools Powering the Future of Biomanufacturing (2025 Edition)
Explore the leading AI platforms transforming biomanufacturing in 2025. Learn what sets the best bioprocess AI software apart and how Invert is redefining real-time manufacturing intelligence.
Read article
What Is Bioprocess AI? How Artificial Intelligence Is Transforming Manufacturing Intelligence
Learn how Bioprocess AI software unifies data, accelerates decision-making, and drives faster scale-up in biomanufacturing. Discover why the next wave of manufacturing intelligence starts with live, trusted data.
Read article
Why Bioprocess Data Fragmentation Is Slowing Down the Industry
Learn how fragmented bioprocess data creates risk, waste, and delays, and how an AI-ready data foundation helps unify insights, accelerate scale-up, and improve manufacturing outcomes.
Read article
AI That Bioprocess Teams Can Trust: Highlights from BioTalk Berlin
Recorded live at BioTalk Berlin on September 18, 2025 — featuring Michael McCutchen, Senior Product Manager at Invert. Scroll to the end to watch the full talk.
Read article
The Best Real-Time Bioprocess Monitoring Platform for Biomanufacturing
See why Invert is the best real-time bioprocess monitoring platform for pharmaceutical manufacturing and scale-up. Live data, AI insights, compliance-ready.
Read article
7 Best AI Bioprocess Optimization Platforms for Pharmaceutical Manufacturing in 2025
The bioprocess optimization market is growing from $24.3B in 2024 to $39.6B by 2029, fueled by the shift to AI-driven digital biomanufacturing. These AI bioprocess platforms are leading the charge.
Read article
Best Bioprocess Data Integration Platforms for Pharmaceutical Manufacturing Teams in 2025
Pharmaceutical manufacturers face critical data integration challenges as bioprocess operations generate unprecedented volumes of fragmented information. Learn more about which leading platforms are also offering AI.
Read article
A Guide to Build vs Buy: Biotech Software Edition
For biotech and synthetic biology companies, there’s always A LOT of work to do. As these companies quickly learn, trying to handle everything in-house–from strain design and high-throughput screening to process development and beyond–can spread funding and resources thinly.
Read article
Bioprocess Tech Transfer: Navigating The Data Dilemma
The transfer of institutional data and knowledge is critical to the development of biotechnologies, bioproducts, and biotherapeutics.
Read article
Why Have Bioprocess Data Solutions Been Overlooked…Until Now?
Given the glaring challenge of managing bioprocess data, the question remains: Why have bioprocess data solutions been historically overlooked?
Read article